Citigroup
RVMD icon

Citigroup’s Revolution Medicines RVMD Stock Holding History

Citigroup’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,000
Closed -$1.1M – 6289
2025
Q2 		$1.1M Hold
30,000
– – ﹤0.01% 3124
2025
Q1 		$1.06M Buy
+30,000
New +$1.22M ﹤0.01% 3221
2024
Q3 		– Sell
-29,900
Closed -$1.16M – 5786
2024
Q2 		$1.16M Buy
+29,900
New +$1.12M ﹤0.01% 2809
2024
Q1 		– Sell
-25,000
Closed -$717K – 5826
2023
Q4 		$717K Buy
+25,000
New +$601K ﹤0.01% 3112

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Citigroup's RVMD Position: Q2 2026 in Review

Citigroup increased its Revolution Medicines (RVMD) stake by 175% in Q2 2026, buying an estimated $23M and bringing the position to 247,052 shares worth $46.3M. The position accounts for 0.02% of the portfolio, ranked #770.

Citigroup first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Citigroup held 247,052 shares of Revolution Medicines worth $46.3M as of Q2 2026.
  • Citigroup bought 157,310 Revolution Medicines shares in Q2 2026, an estimated $23M.
  • Revolution Medicines made up 0.02% of Citigroup's portfolio in Q2 2026, its #770 holding.
  • Citigroup first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.